Robert Miller
Net worth: 42 310 $ as of 30/06/2026
Net worth: 42 310 $ as of 30/06/2026
Robert Matthew Miller is the founder of Fulcrum Pharma Plc, Artemida Pharma Ltd, and Scancell Holdings Plc.
He is currently the Medical Director at Scancell Holdings Plc, a Member at the American Society of Clinical Oncology, Inc., and a Member at the European Society for Medical Oncology.
Previously, he worked as the Director-Clinical Development at Protodigm Ltd., the Chief Medical Officer at Opsona Therapeutics Ltd., and the Chief Consultancy Physician at Aptiv Solutions, Inc. Dr. Miller holds a doctorate degree from the University of London and The Royal College of Surgeons of England.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Foresight Enterprise VCT Plc
Foresight Enterprise VCT Plc Investment ManagersFinance Functions as a private equity fund 0.02% | 01/06/2026 | 69,000 ( 0.02% ) | 42 310 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| SCANCELL HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 17/11/2020 |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Artemida Pharma Ltd. | Founder | - |
| Companies | Position | End |
|---|---|---|
Aptiv Solutions, Inc.
Aptiv Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Corporate Officer/Principal | - |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Chief Tech/Sci/R&D Officer | - |
Protodigm Ltd. | Corporate Officer/Principal | - |
Fulcrum Pharma Plc
Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Provides strategic drug development and regulatory service to the pharmaceutical and biotechnology industries | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Fulcrum Pharma Plc
Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Provides strategic drug development and regulatory service to the pharmaceutical and biotechnology industries | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
Scancell Holdings Plc
Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Protodigm Ltd. | |
The Royal College of Surgeons of England
The Royal College of Surgeons of England Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptiv Solutions, Inc.
Aptiv Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Commercial Services |
Artemida Pharma Ltd. |
Select your edition
All financial news and data tailored to specific country editions